Skip to content

Evaluation of Flexofytol® PLUS in Hand Joint Chronic Dyscomfort.

CompletedNCT05089318
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the effect of curcuminoids and Boswellia serrata extracts combination (Flexofytol PLUS) in support to standard treatments during a 12-weeks period on hand pain on people with chronic hand joint discomfort.

Study details

Official title
Curcuminoids and Boswellia Serrata Extracts Combination Decreases Hand Joint Discomfort : Results From a Belgian Real-Life Experience
Conditions
  • Hand Joint Discomfort
Interventions
  • Dietary supplement: Flexofytol PLUS
Sponsor
Tilman S.A.
Start date
2019-09-01
Primary completion
2021-09-01
Sex
All
Age range
from 45 Years
Results posted
No results posted in this snapshot
Countries
Belgium
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Older dan 45 years old, * With hand joint chronic discomfort, * Regularly uses of paracetamol or NSAIDs to manage pain, * Painful symptoms must have been present for more than 6 months, * The patient assesses their pain on a visual pain scale and must be greater than 4 out of 10 over the last 48 hours. Exclusion Criteria: * Related to previous and associated treatments: * Corticosteroids injection in the 3 previous months, whatever the joint concerned, * Use of Slow-acting drugs for OA and/or dietary supplements taken within less than 6 months prior to the study (ex: chondroitin sulfate, diacerein, soy and avocado unsaponifiables, oxaceprol, granions de cuivre, glucosamine, phytotherapy or homeopathy for hand joint discomfort..), * Anticoagulant (coumarinic) treatment and heparin, * General corticotherapy in the 3 previous months, * Contraindication to paracetamol, curcumin, boswellia and NSAID's. * Related to associated pathologies: * Patient suffering from serious associated illness (liver failure, kidney failure, non-controlled cardiovascular diseases...), * The patient has rheumatoid arthritis or gout, * The patient has a bile obstruction. * Related to patient: * Pregnant or breastfeeding women.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05089318